Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 3
1974 2
1975 1
1976 3
1977 5
1978 1
1979 7
1980 6
1981 7
1982 12
1983 10
1984 14
1985 18
1986 19
1987 13
1988 28
1989 21
1990 24
1991 12
1992 17
1993 28
1994 25
1995 19
1996 15
1997 11
1998 20
1999 14
2000 19
2001 16
2002 11
2003 9
2004 10
2005 5
2006 3
2007 3
2008 2
2009 7
2010 2
2011 2
2012 1
2015 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Results by year

Filters applied: . Clear all
Page 1
Leflunomide and methotrexate.
Laan RF, van Riel PL, van de Putte LB. Laan RF, et al. Among authors: van de putte lb. Curr Opin Rheumatol. 2001 May;13(3):159-63. doi: 10.1097/00002281-200105000-00002. Curr Opin Rheumatol. 2001. PMID: 11333342 Review.
Adult-onset Still's disease.
van de Putte LB, Wouters JM. van de Putte LB, et al. Baillieres Clin Rheumatol. 1991 Aug;5(2):263-75. doi: 10.1016/s0950-3579(05)80283-3. Baillieres Clin Rheumatol. 1991. PMID: 1756584 Review.
Apoptosis and autoimmunity.
Clemens MJ, van Venrooij WJ, van de Putte LB. Clemens MJ, et al. Among authors: van de putte lb. Cell Death Differ. 2000 Jan;7(1):131-3. doi: 10.1038/sj.cdd.4400633. Cell Death Differ. 2000. PMID: 10858073 No abstract available.
Disease activity score.
van der Heijde DM, van't Hof MA, van Riel PL, Van de Putte L. van der Heijde DM, et al. Among authors: van de putte l. Ann Rheum Dis. 1992 Jan;51(1):140. Ann Rheum Dis. 1992. PMID: 1540024 Free article. No abstract available.
Methotrexate: anti-inflammatory or immunosuppressive?
van de Putte LB, Boerbooms AM, Barrera P, Kerstens PJ, Jeurissen ME. van de Putte LB, et al. Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S97-9. Clin Exp Rheumatol. 1993. PMID: 8324961 Review.
Controversies in COX-2 selective inhibition.
Simon LS, Smolen JS, Abramson SB, Appel G, Bombardier C, Brater DC, Breedveld FC, Brune K, Burmester GR, Crofford LJ, Dougados M, DuBois RN, Fitzgerald GA, Frishman W, García Rodríguez LA, Hochberg MC, Kalden JR, Laine L, Langman MJ, Prescott SM, van de Putte LB, Whelton A, White WB, Willaims GH. Simon LS, et al. Among authors: van de putte lb. J Rheumatol. 2002 Jul;29(7):1501-10. J Rheumatol. 2002. PMID: 12136912 Review. No abstract available.
Second-line treatment in seronegative spondylarthropathies.
Creemers MC, van Riel PL, Franssen MJ, van de Putte LB, Gribnau FW. Creemers MC, et al. Among authors: van de putte lb. Semin Arthritis Rheum. 1994 Oct;24(2):71-81. doi: 10.1016/s0049-0172(05)80001-0. Semin Arthritis Rheum. 1994. PMID: 7839156 Review.
Cyclooxygenase in biology and disease.
Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. Dubois RN, et al. Among authors: van de putte lb. FASEB J. 1998 Sep;12(12):1063-73. FASEB J. 1998. PMID: 9737710 Free article. Review.
441 results